General Information of Drug (ID:
DR1475) |
Drug Name |
Sertindole
|
Synonyms |
SerLect; Serdolect; Sertindol; Sertindol [INN-Spanish]; Sertindolum; Sertindolum [INN-Latin]; Lu 23-174; Lu-23-174; SERTINDOLE; 1-(2-(4-(5-Chloro-1-(4-fluorophenyl)-1H-indole-3-yl)-1-piperidinyl)ethyl)-2-imidazolidinone; 1-(2-(4-(5-Chloro-1-(p-fluorophenyl)indol-3-yl)piperidino)ethyl)-2-imidazolidinone; 1-(2-{4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]piperidin-1-yl}ethyl)imidazolidin-2-one; 106516-24-9; CHEBI:9122; CHEMBL12713; GVV4Z879SP; GZKLJWGUPQBVJQ-UHFFFAOYSA-N; MFCD00867749; NCGC00181782-02; UNII-GVV4Z879SP
|
Indication |
Schizophrenia
[ICD11: 6A20]
|
Phase 4
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
440.9 |
Topological Polar Surface Area |
40.5 |
Heavy Atom Count |
31 |
Rotatable Bond Count |
5 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
3 |
Cross-matching ID |
- PubChem CID
- 60149
- PubChem SID
-
9770
; 7784967
; 7847627
; 7980592
; 8186683
; 12014521
; 14905937
; 43117580
; 46504717
; 48404531
; 48404532
; 49658631
; 49980396
; 50126331
; 57313990
; 77724750
; 85210033
; 96099950
; 103173691
; 103916159
; 104319988
; 117509987
; 124893731
; 125680554
; 126683187
; 128028443
; 134338112
; 135018676
; 135651037
; 135697546
; 136949646
; 137001500
; 141946620
; 144206958
; 144206971
; 152102035
; 160967846
; 163123216
; 164764990
; 170465613
; 175268585
; 175611946
; 176246043
; 179149542
; 186006552
; 196408596
; 204360402
; 210275096
; 210280735
; 223382206
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0OS6O
- Formula
- C24H26ClFN4O
- Canonical SMILES
- C1CN(CCC1C2=CN(C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)F)CCN5CCNC5=O
- InChI
- 1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)
- InChIKey
- GZKLJWGUPQBVJQ-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.